Trial Profile
A Phase II/III clinical trial to assess safety and immune response of Trivalent, Live Attenuated Seasonal Influenza vaccine of SIIL in Adults, Elderly and Pediatric Populations
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Influenza vaccine live attenuated (Nasovac-S) (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 25 Aug 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India
- 29 May 2012 Status changed from not yet recruiting to active, no longer recruiting.
- 14 May 2012 Actual end date (25 Aug 2012) added as reported by Clinical Trials Registry - India